RDW-CV/albumin ratio (RAR) superior to other blood cell ratios in predicting short-term outcomes for patients presenting with STEMI after percutaneous coronary intervention (PCI)

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Manuel Arturo Rosario Espinal

Sarasota Memorial Hospital, Sarasota (United States of America)

3 More presentations in this session

Presentation thumbnail

Neutrophil to lymphocyte ratio correlates with both, stress and inflammatory markers and is associated with clinical presentation and mortality in acute coronary syndrome

Doctor S. Swieszkowski (Buenos Aires, AR)

Abstract Slides Video

Presentation thumbnail

Microalbuminuria as an independent predictor of long-term mortality in diabetic and non-diabetic patients with acute coronary syndromes

Doctor A. Valdes (Buenos Aires, AR)

Abstract Slides Video

Presentation thumbnail

A prospective study assessing the clinical utility of novel lipid parameters and the TyG index for risk stratification among patients with STEMI

Doctor X. Zhao (Beijing, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Biomarkers in acute coronary syndrome

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Albumin-based inflammation scores with integrated thrombotic markers outperform conventional predictors for mortality in acute coronary syndrome and atrial fibrillation

Congress Presentation

Common predictors of death in patients with STEMI and NSTEMI during 1st year of postinfarction period

Congress Presentation

Novel platelet-to-lymphocyte and glucose-to-lymphocyte ratios as prognostic markers in acute coronary syndrome

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources